US Broker Ratings

aTyr Pharma, Inc. (ATYR) Stock Analysis: A Biotech Firm with a 444% Potential Upside

Investors with an eye on the biotechnology sector may find aTyr Pharma, Inc. (NASDAQ: ATYR) an intriguing opportunity, given the company’s potential for significant upside. With a market capitalization of..

TotalEnergies SE (TTE) Stock Analysis: Navigating a 9.36% Upside Potential in a Dynamic Energy Sector

TotalEnergies SE (NYSE: TTE), a prominent player in the integrated oil and gas sector, offers a compelling investment opportunity amidst a rapidly evolving energy landscape. With a market capitalization of..

Exxon Mobil Corporation (XOM) Stock Analysis: Exploring a Potential 7.72% Upside Amidst Dividend Strength

As one of the world’s largest publicly traded oil and gas companies, Exxon Mobil Corporation (NYSE: XOM) is a cornerstone of the energy sector, commanding a market capitalization of approximately..

Olema Pharmaceuticals, Inc. (OLMA): Investor Outlook on a Promising Biotech with 202% Upside Potential

Olema Pharmaceuticals, Inc. (NASDAQ: OLMA) is capturing attention in the biotechnology sector with its compelling focus on developing breakthrough therapies for women’s cancers. As a clinical-stage biopharmaceutical company, Olema is..

NANO-X IMAGING LTD (NNOX): Investor Outlook Reveals 154.93% Potential Upside

Nano-X Imaging Ltd. (NNOX) is capturing investor attention with a remarkable potential upside of 154.93%, according to recent analyst ratings. The Israel-based healthcare company, focused on revolutionizing medical imaging through..

Mereo BioPharma Group plc (MREO): Investor Outlook with a 284% Potential Upside

Mereo BioPharma Group plc (NASDAQ: MREO) is making waves in the biotechnology sector with its promising therapeutic developments targeting oncology and rare diseases. Based in the United Kingdom, the company..

Chevron Corporation (CVX) Stock Analysis: Navigating a 12.24% Potential Upside in the Energy Sector

Chevron Corporation (NYSE: CVX), a stalwart in the energy sector, commands significant attention from investors with its substantial market capitalization of $306.54 billion. Positioned within the Oil & Gas Integrated..

The Pennant Group, Inc. (PNTG) Stock Analysis: Exploring a 32.11% Potential Upside

The Pennant Group, Inc. (NASDAQ: PNTG) commands attention in the healthcare sector with its distinctive focus on home health, hospice services, and senior living facilities. Headquartered in Eagle, Idaho, and..

Mineralys Therapeutics (MLYS) Stock Analysis: Uncovering Growth Potential in the Biotech Sector

Mineralys Therapeutics, Inc. (MLYS) is drawing significant attention in the biotechnology space as it continues to make strides in the development of innovative treatments for cardiorenal conditions. With a market..

Healthcare Services Group, Inc. (HCSG) Stock Analysis: Exploring a 25% Potential Upside

Healthcare Services Group, Inc. (NASDAQ: HCSG) stands as a compelling opportunity within the Healthcare sector, particularly in the Medical Care Facilities industry. With a market capitalization of $1.24 billion, HCSG..

BioLife Solutions, Inc. (BLFS) Stock Analysis: A Compelling 20.96% Potential Upside in the Thriving Cell and Gene Therapy Sector

BioLife Solutions, Inc. (NASDAQ: BLFS) is making waves in the healthcare sector, particularly within the medical instruments and supplies industry. With a market capitalization of $1.27 billion, BioLife Solutions is..

Pacira BioSciences, Inc. (PCRX) Stock Analysis: Exploring a 23.97% Potential Upside in the Non-Opioid Pain Management Sector

Pacira BioSciences, Inc. (NASDAQ: PCRX), a prominent player in the healthcare sector, specializes in developing and marketing non-opioid pain management and regenerative health solutions. With a market capitalization of approximately..

NeoGenomics, Inc. (NEO) Stock Analysis: Growth Potential amid Positive Analyst Consensus

NeoGenomics, Inc. (NEO) stands out in the healthcare sector with its specialized focus on diagnostics and research, particularly in cancer-focused testing laboratories. As the company navigates the complexities of the..

Innoviva, Inc. (INVA) Stock Analysis: A Bold 74% Upside Potential for Biotech Investors

Innoviva, Inc. (NASDAQ: INVA) stands out in the biotechnology sector with a remarkable potential upside of 74.41%, according to analyst ratings. With a market capitalization of $1.56 billion, Innoviva engages..

Harrow, Inc. (HROW) Stock Analysis: Eyeing a 99.69% Upside in the Rapidly Growing Eyecare Sector

Harrow, Inc. (HROW) is making waves in the healthcare sector, specifically within the niche of ophthalmic pharmaceuticals. Founded in 1998 and headquartered in Nashville, Tennessee, the company has recently transformed..

Travere Therapeutics (TVTX) Stock Analysis: A 20% Upside Potential in the Biotech Arena

Travere Therapeutics, Inc. (NASDAQ: TVTX), a notable player in the biotechnology sector, has caught the attention of investors with its promising growth trajectory and substantial upside potential. The company, specializing..

Biohaven Ltd. (BHVN) Stock Analysis: A 440% Upside Potential in the Biotech Sector

For investors with an appetite for high-risk, high-reward opportunities, Biohaven Ltd. (NASDAQ: BHVN) presents an intriguing proposition. This biotech company, headquartered in New Haven, Connecticut, has carved a niche in..

Omnicell, Inc. (OMCL) Stock Analysis: Exploring a 28.59% Potential Upside in Healthcare Innovation

Omnicell, Inc. (NASDAQ: OMCL) stands as a compelling player within the healthcare sector, particularly in the health information services industry. With a market capitalization of $1.65 billion, Omnicell is not..

ANI Pharmaceuticals, Inc. (ANIP) Stock Analysis: Impressive Revenue Growth and a Promising 23.55% Upside

ANI Pharmaceuticals, Inc. (NYSE: ANIP) is gaining attention in the healthcare sector with its robust performance metrics and promising analyst ratings, making it a compelling choice for investors seeking growth..

Dynavax Technologies Corp (DVAX) Investor Outlook: Exploring a 106.52% Potential Upside

Dynavax Technologies Corporation (NASDAQ: DVAX) stands out in the healthcare sector, specifically within the specialty and generic drug manufacturing industry. With a market capitalization of $1.3 billion, this Emeryville, California-based..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds